ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 121 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,994,204 | -33.2% | 99,412 | -6.1% | 0.00% | -33.3% |
| Q2 2023 | $2,986,676 | +215.3% | 105,873 | +92.3% | 0.01% | +200.0% |
| Q1 2023 | $947,202 | -35.9% | 55,070 | -24.9% | 0.00% | -33.3% |
| Q4 2022 | $1,477,288 | -14.4% | 73,351 | -8.0% | 0.00% | -25.0% |
| Q3 2022 | $1,726,000 | -21.0% | 79,766 | +2.5% | 0.00% | 0.0% |
| Q2 2022 | $2,184,000 | -19.2% | 77,788 | +32.7% | 0.00% | -20.0% |
| Q1 2022 | $2,703,000 | -45.7% | 58,619 | -1.1% | 0.01% | -37.5% |
| Q4 2021 | $4,980,000 | +30.0% | 59,264 | +3.0% | 0.01% | +33.3% |
| Q3 2021 | $3,831,000 | +54.9% | 57,513 | +23.6% | 0.01% | +50.0% |
| Q2 2021 | $2,474,000 | +144.7% | 46,523 | +99.4% | 0.00% | +100.0% |
| Q1 2021 | $1,011,000 | -16.6% | 23,336 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $1,212,000 | – | 23,336 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Decheng Capital Management III (Cayman), LLC | 1,824,583 | $39,520,000 | 14.33% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 2,301,771 | $49,857,000 | 4.79% |
| Matrix Capital Management Company, LP | 9,199,973 | $199,271,000 | 3.81% |
| Integral Health Asset Management, LLC | 550,000 | $11,913,000 | 2.31% |
| Avidity Partners Management LP | 4,223,100 | $91,472,000 | 1.86% |
| Affinity Asset Advisors, LLC | 170,000 | $3,682,000 | 1.03% |
| Eventide Asset Management | 1,861,000 | $40,309,000 | 0.79% |
| Sofinnova Investments, Inc. | 583,357 | $12,636,000 | 0.74% |
| Nicholas Investment Partners, LP | 158,704 | $3,438,000 | 0.32% |
| SECTORAL ASSET MANAGEMENT INC | 60,000 | $1,300,000 | 0.26% |